Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,231 public trials 1,018 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

A Non Interventional Pilot Study on Machine Learning for ILD Detection Based on the Patient Data From Digital Devices in Unresectable Stage III Non-Small Cell Lung Cancer Patients Receiving Durvalumab

NCT04884269

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Research Site Nagoya, Aichi-ken, Japan
  • Research Site Nagoya, Aichi-ken, Japan
  • Research Site Toyoake, Aichi-ken, Japan
  • Research Site Matsuyama, Ehime, Japan
View all 27 locations
View Trial Details
Completed

A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer

NCT03639194

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of Alabama at Birmingham - Main /ID# 207295 Birmingham, Alabama, United States
  • Highlands Oncology Group, PA /ID# 207176 Springdale, Arkansas, United States
  • University of California, Davis Comprehensive Cancer Center /ID# 207548 Sacramento, California, United States
  • Yale School of Medicine /ID# 207559 New Haven, Connecticut, United States
View all 32 locations
View Trial Details
Completed

Accelerated Radio-Immunotherapy for Lung Cancer

NCT04577638

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Centre Hospitalier de Brest Brest, France
  • Centre de Lutte Contre le Cancer François Baclesse Caen, France
  • Centre de Lutte contre le Cancer Oscar Lambret Lille, France
  • Valérie JOLAINE Rennes, France
View Trial Details
Completed

Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer

NCT03892096

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +23 more
Locations
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • Sutter Health - Palo Alto Medical Foundation Sunnyvale, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • IACT Health Columbus, Georgia, United States
View Trial Details
Completed

A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer

NCT02789345

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Villejuif, France
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cheong Ju-City, South Korea
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seongnam, South Korea
View Trial Details

Related conditions